ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FOXH Foxhollow Technologies (MM)

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Foxhollow Technologies (MM) NASDAQ:FOXH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

FoxHollow Technologies to Participate in William Blair 27th Annual Growth Stock Conference

15/06/2007 2:00pm

PR Newswire (US)


Foxhollow (NASDAQ:FOXH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Foxhollow Charts.
REDWOOD CITY, Calif., June 15 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, is scheduled to participate in the William Blair 27th Annual Growth Stock Conference on Wednesday, June 20, 2007, in Chicago, Illinois. Matt Ferguson, chief financial officer, will provide an update on the company at 9:10 a.m. Pacific Time (12:10 p.m. Eastern Time). A live audio webcast of the presentation will be available via the Internet at http://investor.foxhollowtech.com/ and will be available for replay for approximately three months. About FoxHollow Technologies FoxHollow Technologies, Inc. develops and markets minimally invasive devices for the removal of plaque and thrombus for the treatment of peripheral artery disease (PAD). PAD results from plaque that accumulates in the arteries and blocks blood flow in the legs. These blockages can result in severe pain for patients and very limited physical mobility. The company's SilverHawk Plaque Excision System is a minimally invasive method of removing the obstructive plaque and restoring blood flow to the legs and feet. The company's Rinspirator thrombectomy system removes thrombus, or blood clots, from occluded arteries in patients suffering from PAD or coronary artery disease (CAD). For more information, please visit our website at http://www.foxhollowtech.com/. Contacts Investor Relations: Matt Ferguson Chief Financial Officer 650-421-8449 DATASOURCE: FoxHollow Technologies, Inc. CONTACT: Matt Ferguson, Chief Financial Officer of FoxHollow Technologies, Inc., +1-650-421-8449, Web site: http://www.foxhollowtech.com/

Copyright

1 Year Foxhollow Chart

1 Year Foxhollow Chart

1 Month Foxhollow Chart

1 Month Foxhollow Chart

Your Recent History

Delayed Upgrade Clock